| Ytd | -10.41% | |
| 1y | -60.64% |
| Open | 0.50 | Prev Close | 0.48 | Low | 0.46 | High | 0.50 | Mkt Cap | 10.59M |
| Vol | 106.72K | Avg Vol | 603.30K | EPS | -0.47 | P/E | -1.02 | Forward P/E | -6.39 |
| Beta | 4.00 | Short Ratio | 0.56 | Inst. Own | 2.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.42 | 200-d Avg | 0.67 | 1yr Est | 3.00 |
NXL News
Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-mar
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar
Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-marke
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday'
Accepted abstracts showcase Nexalin's proprietary DIFS™ 15 mA 77.5 Hz treatment platform and cli
Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in no
Nexalin reports Brazil trial gains in anxiety, depression and sleep, plus U.S. patent protection thr
The United States Patent and Trademark Office has issued U.S. Patent No. 12,629,519, titled: "Tr
The U.S. House of Representatives-approved report language, which was secured through the Company
Through the transaction, Nexalin has secured ownership of PONM and an exclusive license to the propr
The study, titled: "Modulating Default and Salience/Ventral Attention networks: Exploring the tr
Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in no
IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline
Nexalin study shows reduced self-injury and depression in adolescents using DIFS, with brain connect
Nexalin Technology (NASDAQ:NXL) reported quarterly losses of $(0.13) per share which missed the anal
Nexalin advances a 150-patient U.S. insomnia trial for HALO Clarity, supporting its planned FDA subm
The pivotal study to support Nexalin's planned FDA submission builds on Nexalin's previously
Nexalin launched its AI-powered NeuroCare virtual clinic with UC San Diego, enabling at-home brain t
New digital health platform being launched in partnership with UCSD allows remote physician-monitore
Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in no
Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in no
On Thursday, 930 stocks hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.